Lifestyle medicine for Alzheimer's Disease

"Unfortunately, the information located on clinicaltrials.gov states that this medical trial is no longer accepting patients. The study was posted in September 2018 and its last update occurred 4 years later; however, there are over 500 other studies actively seeking enrollees at this time."

"This medical study is recruiting patients aged 45 and above, with a cut-off at 90 years old."

"Presently, 5 medical centres are running this clinical trial with sites in Sausalito, Reno and Boston amongst others. To reduce travel needs if you choose to enroll in the study, it is advantageous to pick a centre that is nearest your current location."

"This research project is enrolling 51 individuals aged between 45 and 90 with alzheimer disease. To be considered, candidates must have a current diagnosis of mild dementia or cognitive impairment due to the condition in question (McKhann-Albert criteria) as well as a MoCA score above 17 (18+). Additionally, they are expected to partake in all parts of this intervention while having access to an associate who can provide corroborating information and aid them through the study's duration."

"This clinical trial seeks to measure the change in Clinical Global Impression of Change (CGIC) score at baseline and after 20 weeks and 40 weeks. Secondary objectives involve quantifying changes from baseline in patients' gut microbiomes, amyloid peptides, and inflammatory biomarkers with 16S rRNA amplicon sequencing, metagenomic sequencing, mass spectrometry testing via Human Aβ Peptide Panel 1 (6E10), Phospho(Thr231)/Total Tau Kit; p-tau 181; p-tau217., as well as Inflammatory Human ProInflammatory 10-Plex: IF"